A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH significantly improved IBS symptoms and quality of life. Among 240 participants, 81% of those using the GDH program experienced a ≥50-point decrease in IBS symptom severity compared to 63% in the control group (P = 0.002). GDH also led to a greater reduction in pain (71% vs. 35%, P < 0.001) and quality-of-life improvements (P < 0.001). These findings support digital GDH as an effective and accessible alternative to in-person behavioral interventions for IBS management.
Trending
- EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial (Business Wire)
- A single blood sample may improve the prediction of colorectal cancer recurrence or metastasis, kaist study finds (EurekAlert)
- At-Home Colorectal Cancer Tests Are Not a One-and-Done Deal (Cancer Health)
- How AI clears the way for colonoscopy screening (American Medical Association)
- Inside Diverticulitis: What Gastroenterologists Need to Know (Medscape)
- Abbott reports diagnostics growth since $21B Exact Sciences buy (Medtech Dive)
- Video Capsule Endoscopy Has Widening Role Beyond Diagnosis of Small-Bowel Bleeding (GI & Endoscopy News)
- How the AGA Incubator is shaping the future of digestive health (AGA)
